BIS
ProShares UltraShort Nasdaq Biotechnology
NASDAQFinancial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
Frequently Asked Questions
Common questions about BIS
ProShares UltraShort Nasdaq Biotechnology (BIS) is a publicly traded company listed on NASDAQ. ProShares UltraShort Nasdaq Biotechnology (BIS) is an ETF included in the Stock Monitor database for research and watchlists. It operates in the ETF industry within the ETF sector.
The current stock price of BIS is $477.30, with a change of -3.70% in the latest session. Stock prices are updated during market hours and may be delayed.
BIS does not currently pay regular dividends. Many growth companies choose to reinvest earnings into the business rather than distribute them as dividends.
BIS belongs to the ETF sector specifically in the ETF industry. Understanding a company's sector helps investors compare it to peers and understand industry-specific trends that may affect performance.
Trade
Buy/Sell via broker links (affiliate).
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Price Alerts
Notify when BIS crosses your target.
Company Info
What does this mean?About
ProShares UltraShort Nasdaq Biotechnology (BIS) is an ETF included in the Stock Monitor database for research and watchlists.